Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (42,942,198)	$ (40,854,855)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	7,614,321	5,196,156
Issuance of shares in licensing agreement	0	4,999,988
Issuance of shares in consulting agreement	1,021,000	0
Amortization of debt discount	652,006	183,914
Depreciation expense	17,359	86
Operating lease expense	160,685	241,029
Finance lease amortization expense	39,967	48,992
Changes in operating assets and liabilities:
Prepaid expenses and other assets	165,672	(1,062,661)
Finance lease right-to-use asset	0	(423,880)
Accounts payable	5,763,537	(90,116)
Accrued expenses	(5,889,016)	6,126,004
Finance lease liabilities	0	220,625
Operating lease liabilities	(239,469)	(294,988)
Net cash used in operating activities	(33,636,136)	(25,709,706)
Cash flows from financing activities:
Proceeds from issuance of note payable	0	25,000,000
Payment for debt issuance costs	0	(449,329)
Proceeds from exercise of stock options	308,942	151,416
Payments of finance lease obligations	(59,300)	0
Payment of taxes in equity transaction	0	(270,959)
Proceeds from issuances of common stock, net of issuance costs	16,126,851	9,856,116
Net cash provided by financing activities	16,376,493	34,287,244
Net (decrease) increase in cash and cash equivalents	(17,259,643)	8,577,538
Cash and cash equivalents at beginning of period	73,820,160	65,242,622
Cash and cash equivalents at end of period	56,560,517	73,820,160
Supplemental information of cash and non-cash transactions:
Cash paid for interest	3,535,071	852,221
Fair value of warrants issued in connection with debt	$ 0	$ 1,713,741